Page 34 - 《中国药房》2022年19期
P. 34

compound suppresses distant metastasis of colorectal can‐  EMT during cancer initiation and progression[J]. Nat Rev
               cer by targeting the oncogenic KITENIN complex[J]. Mol  Cancer,2013,13(2):97-110.
               Cancer,2021,20(1):78.                          [18]  LI Q Y,LAI Q H,HE C C,et al. RUNX1 promotes tu‐
          [14]  ZHONG Y,LONG T,GU C S,et al. MYH9-dependent po‐    mour metastasis by activating the Wnt/β -catenin signal‐
               larization of ATG9B promotes colorectal cancer metasta‐  ling pathway and EMT in colorectal cancer[J]. J Exp Clin
                                                                   Cancer Res,2019,38(1):334.
               sis by accelerating focal adhesion assembly[J]. Cell Death
                                                              [19]  CHERIYAMUNDATH S,BEN-ZE'EV A. Wnt/β -catenin
               Differ,2021,28(12):3251-3269.
                                                                   target genes in colon cancer metastasis:the special case of
          [15]  BILLER L H,SCHRAG D. A review of the diagnosis and
                                                                   L1CAM[J]. Cancers,2020,12(11):3444.
               treatment of metastatic colorectal cancer-reply[J]. JAMA,
                                                              [20]  WANG W,LIU H Y,WANG S,et al. A diterpenoid de‐
               2021,325(23):2405.                                  rivative 15-oxospiramilactone inhibits Wnt/β-catenin sig‐
          [16]  ZANOTELLI M R,ZHANG J,REINHART-KING C A.           naling and colon cancer cell tumorigenesis[J]. Cell Res,
               Mechanoresponsive metabolism in cancer cell migration  2011,21(5):730-740.
               and metastasis[J]. Cell Metab,2021,33(7):1307-1321.          (收稿日期:2022-03-04 修回日期:2022-08-25)
          [17]  DE CRAENE B,BERX G. Regulatory networks defining                                  (编辑:唐晓莲)







          







         (上接第2325页)
          参考文献                                                    (L.)L. :extraction method study and quantification[J]. J
          [ 1 ]  国家药典委员会 . 中华人民共和国药典:一部[S]. 2020                   Sep Sci,2008,31(6/7):945-952.
               年版.北京:中国医药科技出版社,2020:355-356.                  [ 9 ]  SHOAIB A,DIXIT R K,BADRUDDEEN,et al. Cure of
          [ 2 ]  GUO C J,HE J L,SONG X,et al. Pharmacological pro-  human diabetic neuropathy by HPLC validated bark ex‐
               perties and derivatives of shikonin:a review in recent  tract of Onosma echioides L. root[J]. Nat Prod Res,2019,
                                                                   33(18):2699-2703.
               years[J]. Pharmacol Res,2019,149:104463.
                                                              [10]  国家药典委员会 . 中华人民共和国药典:四部[S]. 2020
          [ 3 ]  中国科学院中国植物志编辑委员会 . 中国植物志:第五
                                                                   年 版 . 北 京 :中 国 医 药 科 技 出 版 社 ,2020:39,59,
               十九卷第一分册[M].北京:科学出版社,1989:53.
                                                                   114,234.
          [ 4 ]  KUMAR N,KUMAR R,KISHORE K. Onosma L.:a re‐
                                                              [11]  黄建猷,胡筱希,谭晓,等 . 瑶药消瘤藤的质量标准研究
               view of phytochemistry and ethnopharmacology[J]. Phar‐
                                                                   [J].中国药房,2021,32(21):2624-2630.
               macogn Rev,2013,7(14):140-151.
                                                              [12]  昝珂,苏蕊,滕爱君,等 . 新疆紫草 HPLC 特征图谱和紫
          [ 5 ]  SHOAIB A,BADRUDDEEN,DIXIT R K,et al. Benefi‐
                                                                   草类药材 6 种萘醌类成分含量测定[J]. 药物分析杂志,
               cial effects of n-hexane bark extract of Onosma echioides
                                                                   2016,36(9):1526-1535.
               L. on diabetic peripheral neuropathy[J]. J Cell Biochem,
                                                              [13]  马留纯,马生军,朱金芳,等 . 新疆紫草的 HPLC 指纹图
               2019,120(10):16524-16532.                           谱建立、化学模式识别分析及其含量测定[J].中国药房,
          [ 6 ]  NIKITA G,VIVEK P,CHHAYA G. Wound-healing acti-    2020,31(14):1732-1738.
               vity of an oligomer of alkannin/shikonin,isolated from  [14]  WANG F F,MAYCA POZO F,TIAN D M,et al. Shiko‐
               root bark of Onosma echioides[J]. Nat Prod Res,2015,29  nin inhibits cancer through P21 upregulation and apopto‐
              (16):1584-1588.                                      sis induction[J]. Front Pharmacol,2020,11:861.
          [ 7 ]  邵鑫,蒋先虹,王瑞,等.紫草素对人结肠癌细胞HCT116                 [15]  詹志来,郭兰萍,金艳,等 . 中药材品质评价与规格等级
               自噬和凋亡的影响[J].中国药房,2021,32(1):51-55.                  的历史沿革[J].中国现代中药,2017,19(6):868-876.
          [ 8 ]  SAGRATINI G,CRISTALLI G,GIARDINÀ D,et al. Al‐              (收稿日期:2022-03-21 修回日期:2022-09-01)
               kannin/shikonin mixture from roots of Onosma echioides                             (编辑:胡晓霖)






          ·2332·   China Pharmacy 2022 Vol. 33 No. 19                                 中国药房    2022年第33卷第19期
   29   30   31   32   33   34   35   36   37   38   39